Study estimates 136.8 million U.S. adults are eligible for semaglutide, a popular therapy for diabetes, weight loss, and cardiovascular disease.

Popular anti-obesity drugs continue to show cardiovascular benefits beyond weight loss, according to several new papers published in JACC, the flagship journal of the American College of Cardiology, ...

Your doctor broke news you didn’t want to hear: you have prediabetes, a condition where blood sugar is elevated, but not high ...

More than half of all adults in the U.S. are eligible for semaglutide (Ozempic, Wegovy, Rybelsus), researchers estimated.

New research shows that weight loss medications can stop the progression of prediabetes. Experts don’t all agree on such a ...

Everyone is raving about the slimming power of semaglutide medications like Ozempic and Wegovy, which experts say is as ...

SAN ANTONIO -- Research presented at the ObesityWeek annual meeting included studies on rationing of prescription medications ...

For some people living with diabetes, blood sugar can drop or rise overnight, interrupting sleep. Difficulty sleeping can also affect your insulin. But there are things you can do to manage blood ...

This is not a legal document. The explanations and definitions are not legal definitions. In case of a discrepancy between the language in this document and the relevant legislation or regulations, ...

Take control of prediabetes with these expert-recommended strategies to manage blood sugar and reduce your diabetes risk. If ...

Most Americans are already familiar with semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist that Novo Nordisk markets as Ozempic and Rybelsus for diabetes, and Wegovy for weight ...

Yogurt has gained attention for its health benefits, and recent studies continue to highlight these. The U.S. Food and Drug Administration (FDA) now supports the idea that yogurt in your diet ...